Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 WCG Unveils New Brand Identity | Contract Pharma

What are you searching for?

Sign in
Breaking News

WCG Unveils New Brand Identity

Represents the full integration of WCG's companies and emphasizes WCG's commitment to partner with stakeholders.

By: Anthony Vecchione

WCG, a provider of clinical research services, launched its new brand identity representing the integration of WCG’s companies and its commitment to partner with stakeholders to bring therapies to patients, faster.

As clinical trials face new global headwinds, WCG said that it is uniquely positioned to help the clinical research industry succeed through its three brand pillars: connectivity, data intelligence, and expertise.

• WCG supports connectivity throughout the clinical trial ecosystem with technology solutions, services, data, and expertise to help enable sponsors, CROs, sites, and trial participants to collaborate in navigating increasingly complex protocol requirements.

• WCG leverages data intelligence to help enable clinical trial success. Insights and predictive analytics help clients to detect meaningful patterns, from recruitment trends to historical site performance, to data anomalies and potential safety issues. 

• WCG’s domain expertise help accelerate the development of therapies by improving the conduct and quality of clinical trials.

“WCG began as an ethical review company 55 years ago,” said Sam Srivastava, CEO WCG. “While our origins include pioneering work in that area, through strategic acquisitions and organic growth we have accumulated unmatched domain expertise and evolved into a trusted partner supporting our clients throughout the clinical trial journey. Our new look and feel better reflect our true identity as a leader providing the connectivity, data intelligence, and expertise required to successfully advance clinical research.”

Carmin Gade, chief marketing officer, said, “Our rebranding is more than a new logo,” said Carmin Gade, chief marketing officer. We’ve transformed from the inside out to ensure we’re streamlined and efficient in serving our clients. Our purpose-fit solutions enable the successful advancement of research protocols aimed at improving global health on a massive scale. In 2022, we touched 90 percent of all clinical trials globally.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics